Stock Events

Stock Events

Bod Australia Limited 

A$0.27
3
+A$0+0% Friday 05:36

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22AugExpected
Q2 2018
Q4 2018
Q2 2019
Q4 2019
Q2 2020
Q4 2020
Q2 2021
-0.07
-0.05
-0.02
0
Expected EPS
N/A
Actual EPS
-0.03

Financials

-732.08%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
876,000Revenue
-6.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BDA.AU. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zelira Therapeutics Limited
ZLD.AU
Mkt Cap5.95M
Zelira Therapeutics Ltd is directly competing in the medicinal cannabis sector, focusing on developing branded cannabis products.
ECS Botanics
ECS.AU
Mkt Cap7.98M
Ecofibre Limited operates in the hemp-derived CBD industry, offering similar health and wellness products as Bod Australia.
Cann Group Limited
CAN.AU
Mkt Cap8.87M
Cann Group Limited focuses on the cultivation of medical cannabis and production of cannabis-derived products, competing in the same industry.
Elixinol Wellness Limited
EXL.AU
Mkt Cap3.31M
Elixinol Global Limited operates in the global cannabis market, producing and distributing dietary supplements and skincare products.
IDT Australia
IDT.AU
Mkt Cap17.1M
IDT Australia Limited is involved in pharmaceutical manufacturing, including cannabis-based products, placing them as a competitor.
Botanix Pharmaceuticals Limited
BOT.AU
Mkt Cap87.05M
Botanix Pharmaceuticals Ltd focuses on the development of dermatological products and drug delivery systems, including cannabinoid-based therapies.

About

Bod Australia Limited operates as a cannabidiol and medical cannabis healthcare company in Australia, the United Kingdom, the European Union, and the United States. The company operates through three segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, and OTC Herbals. It engages in the development and manufacture of cannabidiol and hemp products for consumers; and development, manufacture, and distribution of therapeutics medicinal cannabis products for medical markets. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long-term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.
Show more...
CEO
Ms. Joanne Patterson
Country
Australia
ISIN
AU000000BDA5

Listings

0 Comments

Share your thoughts

FAQ

What is Bod Australia Limited stock price today?▼
The current price of BDA.AU is A$0.27 AUD — it has increased by +0% in the past 24 hours. Watch Bod Australia Limited stock price performance more closely on the chart.
What is Bod Australia Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bod Australia Limited stocks are traded under the ticker BDA.AU.
What were Bod Australia Limited earnings last quarter?▼
BDA.AU earnings for the last quarter are -0.03 AUD per share, whereas the estimation was N/A AUD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is Bod Australia Limited revenue for the last year?▼
Bod Australia Limited revenue for the last year amounts to 876,000 AUD.
What is Bod Australia Limited net income for the last year?▼
BDA.AU net income for the last year is -6.41M AUD.
In which sector is Bod Australia Limited located?▼
Bod Australia Limited operates in the Lifestyle & Brands sector.
When did Bod Australia Limited complete a stock split?▼
Bod Australia Limited has not had any recent stock splits.
Where is Bod Australia Limited headquartered?▼
Bod Australia Limited is headquartered in Double Bay, Australia.